Office of Technology Development
Our Mission
To increase and accelerate the impact of Salk science on patients in need – and in so doing, generate revenues that can increase the scope and pace of Salk science.
Office of Technology Development
The Office of Technology Development (OTD) promotes the commercial development of intellectual property created at the Salk Institute. OTD does this by fostering relationships between Salk and industry partners who are willing to license Salk patents and develop products that can help patients in need. OTD evaluates invention disclosures submitted by Salk scientists, identifies the commercial possibilities for these inventions, works with the faculty to begin the patenting process, negotiates and manages technology licenses.
In addition to patentable inventions, we also handle Tangible Research Materials (antibodies, cell lines etc) and Material Transfer Agreements for biological materials.
Click here for Salk innovations>>
Salk Technologies in the News
May 23, 2013
Protein preps cells to survive stress of cancer growth and chemotherapy
May 20, 2013
Timing of cancer radiation therapy may minimize hair loss, researchers say
May 14, 2013
Salk scientists develop drug that slows Alzheimer's in mice
May 09, 2013
Salk researchers chart epigenomics of stem cells that mimic early human development
May 07, 2013
Salk scientists find potential therapeutic target for Cushing's disease
April 10, 2013
Despite what you may think, your brain is a mathematical genius
February 05, 2013
Plants cut the mustard for basic discoveries in metabolism
October 22, 2012
Aggressive brain tumors can originate from a range of nervous system cells
March 21, 2012
Salk scientists open new window into how cancers override cellular growth controls
January 11, 2012
Scientists identify gene crucial to normal development of lungs and brain
December 14, 2011
Alzheimer's drug candidate may be first to prevent disease progression
